Autopsy report · NCT00591669

Non-invasive Imaging of GI Inflammation Using Microbubble Contrast Enhanced Ultrasonography

“Data storage damage plus unexpected loss of funding”

The sponsor’s own words in the registry.

Life of this trial

• Registered 1 year 7 months after it had already started.
• Ran for about 4 years 7 months before it stopped.
• 10 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Na

Sponsor

University of Virginia

Sponsor type

University, hospital or other

Conditions

Inflammatory Bowel Disease

Interventions

Definity; Definity

Participants

10

Sites

1

Countries

United States

Trials that died the same way

• Mycophenolic Acid Monotherapy in Recipients of HLA-identical Living-Related Transplantation
  “Funding loss” (59% match in meaning)
• A Phase II Neoadjuvant Study of Enzalutamide, Abiraterone Acetate, Dutasteride and Degarelix in Men With Localized Prostate Cancer Pre-prostatectomy
  “loss of funding” (59% match in meaning)
• A Commercial Available Tooth Positioner for the Treatment of Simple Orthodontic Relapse
  “losing of funding for the study” (55% match in meaning)
• The Addition of Metformin to Definitive Radiotherapy in Patients With Stage III NSCLC
  “Loss of external funding” (55% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.